Efficacy and safety of adrenomedullin for acute ischemic stroke (AMFIS): a phase 2, randomized, double-blinded, placebo-controlled, clinical trial Authors Kazuki Fukuma (ORCID: https://orcid.org/0000-0001-8117-8916) Eriko Yamaguchi Kazuo Washida (ORCID: https://orcid.org/0000-0003-1396-7790) Katsuhiro Omae (ORCID: https://orcid.org/0000-0001-6722-3311) Masafumi Ihara (ORCID: https://orcid.org/0000-0002-7102-4048) Yorito Hattori (ORCID: https://orcid.org/0000-0002-1495-4433) Tomotaka Tanaka (ORCID: https://orcid.org/0000-0002-6023-236X) Kazuyuki Nagatsuka Hiroyuki Ishiyama (ORCID: https://orcid.org/0000-0003-0071-7338) Soichiro Abe (ORCID: https://orcid.org/0000-0001-9528-8702) Satoshi Saitô (ORCID: https://orcid.org/0000-0001-8608-058X) Takeshi Yoshimoto (ORCID: https://orcid.org/0000-0003-3178-8171) Haruko Yamamoto (ORCID: https://orcid.org/0000-0002-8135-2547) Hiroshi Yamagami (ORCID: https://orcid.org/0000-0001-8133-3314) Masahiro Tsuji (ORCID: https://orcid.org/0000-0002-1540-3641) Toshihiro Kita (ORCID: https://orcid.org/0000-0001-8950-144X) Kenta Tanaka (ORCID: https://orcid.org/0000-0001-7416-4575) Kazuo Kitamura (ORCID: https://orcid.org/0000-0002-5124-9549) Manabu Minami Institutions University of Miyazaki (JP) University of Tsukuba (JP) Kyoto Women's University (JP) Osaka Neurological Institute (JP) National Cerebral and Cardiovascular Center (JP) Funders Japan Agency for Medical Research and Development National Cerebral and Cardiovascular Center Explore the Global Research Space Interactive Map